One-year chronic toxicity evaluation of single dose intravenously administered silica nanoparticles in mice and their Ex vivo human hemocompatibility
- 25 May 2020
- journal article
- research article
- Published by Elsevier BV in Journal of Controlled Release
- Vol. 324, 471-481
- https://doi.org/10.1016/j.jconrel.2020.05.027
Abstract
No abstract availableFunding Information
- Foundation for the National Institutes of Health
- National Science Foundation
- National Institute of Environmental Health Sciences
- National Cancer Institute
This publication has 77 references indexed in Scilit:
- The comparative immunotoxicity of mesoporous silica nanoparticles and colloidal silica nanoparticles in miceInternational Journal of Nanomedicine, 2013
- Silica-based mesoporous nanoparticles for controlled drug deliveryJournal of Tissue Engineering, 2013
- In Vivo Toxicity of Intravenously Administered Silica and Silicon NanoparticlesMaterials, 2012
- Health Evaluation of Experimental Laboratory MiceCurrent Protocols in Mouse Biology, 2012
- Size and surface charge significantly influence the toxicity of silica and dendritic nanoparticlesNanotoxicology, 2011
- Silica nanoconstruct cellular toleration threshold in vitroJournal of Controlled Release, 2011
- The carcinogenic potential of nanomaterials, their release from products and options for regulating themInternational Journal of Hygiene and Environmental Health, 2011
- Impact of Silica Nanoparticle Design on Cellular Toxicity and Hemolytic ActivityACS Nano, 2011
- Metal Oxide Nanoparticles Induce Unique Inflammatory Footprints in the Lung: Important Implications for Nanoparticle TestingEnvironmental Health Perspectives, 2010
- Method for Analysis of Nanoparticle Hemolytic Properties in VitroNano Letters, 2008